Type III chronic prostatitis
Conditions
Interventions
Experimental Group:Acupuncture
Control Group:Tamsulosin Hydrochloride Controlled-Release Capsules
Sponsors
Shanghai Research Institute of Acupuncture and Meridian
Eligibility
Sex/Gender
Male
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: (1) Meets the Western medical diagnostic criteria for Type III chronic prostatitis and the Traditional Chinese Medicine diagnostic criteria for chronic prostatitis with a pattern of damp-heat and blood stasis, with a disease duration of >3 months; (2) Male, aged 18–55 years; (3) NIH-CPSI score =15; (4) HAMD score =8 or HAMA score =8; (5) No other medications for chronic prostatitis have been taken within the past month, and no other treatments for chronic prostatitis have been received; (6) Willing to participate in this study and sign an informed consent form. Translated with DeepL.com (free version)
Exclusion criteria
Exclusion criteria: (1) Acute prostatitis or chronic bacterial prostatitis; (2) Conditions that may cause perineal pain or urinary tract irritation, such as urinary tract infections, urinary stones, diseases of the testicles, epididymis, or spermatic cord, urinary tract tumors, urethral obstruction, overactive bladder, or neurogenic bladder; (3) Patients with conditions affecting lower urinary tract function, such as senile dementia, spinal cord injury, acute or sequelae of cerebrovascular disease, multiple sclerosis, Parkinson's disease, and multiple system atrophy; (4) Patients with severe primary diseases of the heart, brain, liver, or hematopoietic system; (5) Patients with a history of psychiatric disorders or significant cognitive impairment who are unable to cooperate with treatment or complete efficacy assessments; (6) Patients with known contraindications to acupuncture treatment, such as spontaneous bleeding or uncontrolled bleeding following injury, skin infections, or ulcers; or patients with known drug allergies to tamsulosin hydrochloride sustained-release capsules.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI; | — |
Secondary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score,IPSS;Visual Analogue Scale, VAS;Hamilton Depression Rating Scale,HAMD;Hamilton Anxiety Rating Scale, HAMA;Traditional Chinese Medicine (TCM) Syndrome Scoring Scale;prostate ultrasound;Residual urine ultrasound;urine flow rate;5-HT;IL-1ß;TNF-a; | — |
Countries
China
Contacts
Public ContactLiu Hui Rong
Shanghai Research Institute of Acupuncture and Meridian
Outcome results
None listed